Chinook Therapeutics Inc (KDNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 4,799 | 4,888 | 3,938 | 2,758 | 3,063 |
| Gross Profit | 4,799 | 4,888 | 3,938 | 2,758 | 3,063 |
| Operating Expenses | 29,337 | 24,995 | 28,852 | 30,760 | 27,968 |
| Operating Income | -24,538 | -20,107 | -24,914 | -28,002 | -24,905 |
| Other Income | 1,334 | 1,494 | 1,452 | 1,343 | 1,374 |
| Pre-tax Income | -23,204 | -18,613 | -23,462 | -26,659 | -23,531 |
| Income Tax | -2,252 | -35 | -35 | -339 | -385 |
| Net Income Continuous | -20,952 | -18,578 | -23,427 | -26,320 | -23,146 |
| Net Income | $-20,952 | $-18,578 | $-23,427 | $-26,320 | $-23,146 |
| EPS Basic Total Ops | -1.31 | -1.15 | -1.45 | -1.65 | -1.45 |
| EPS Basic Continuous Ops | -1.31 | -1.16 | -1.47 | -1.66 | -1.46 |
| EPS Diluted Total Ops | -1.31 | -1.15 | -1.45 | -1.65 | -1.45 |
| EPS Diluted Continuous Ops | -1.31 | -1.16 | -1.47 | -1.66 | -1.46 |
| EBITDA(a) | $-18,824 | $-19,384 | $-24,039 | $-23,035 | $-23,952 |